Abstract:BACKGROUND: The disorder of LINC01207 has a significant regulatory effect on cancers, nevertheless its role in non-small cell lung cancer (NSCLC) have not been illustrated. This study investigated the regulatory effect of LINC01207 on NSCLC and clarify its molecular mechanism. METHODS: Bioinformatics analysis was used to find the target lncRNA, miRNA and mRNA. LncBase and TargetScan databases predicted the relationship between LINC01207, miR-525-5p and ARHGAP11A. Dual-luciferase reporter gene assay and RNA binding protein immunoprecipitation assay were used to verify the binding relationship between genes. Fluorescence in situ hybridization assay was used to localize the expression of LINC01207 in NSCLC tissue. qRT-PCR and Western blot assays were used to measure the expression of LINC01207, miR-525-5p and ARHGAP11A. CCK-8 assay, Transwell assay and flow cytometry assay were used to detect NSCLC cell abilities. Mouse xenograft models further determined the effect of LINC01207 on the growth of NSCLC in vivo. RESULTS: LINC01207 was up-regulated in NSCLC tissue and cells, which was mainly localized in the cytoplasm. LINC01207 knockdown could inhibit the proliferation, migration and invasion of cancer cells and induce cell apoptosis. In addition, silencing LINC01207 could suppress tumor growth in vivo. LINC01207 could sponge and inhibit the expression of miR-525-5p in NSCLC cells, and inhibiting LINC01207 and miR-525-5p simultaneously could reverse the effect of miR-525-5p on the progression of NSCLC cells. Further study on downstream target genes showed that miR-525-5p could restrain the expression of ARHGAP11A, and then affect the progression of NSCLC. LINC01207 acting as a competing endogenous RNA (ceRNA) could regulate the expression of ARHGAP11A by competitively binding with miR-525-5p. CONCLUSION: LINC01207 regulates the progression of NSCLC by regulating the miR-525-5p/ARHGAP11A axis as a ceRNA and plays a carcinogenic role. In conclusion, our study elucidates the mechanism of LINC01207 regulating the progression of NSCLC, and provides a new idea for the diagnosis and treatment of NSCLC guided by lncRNA.

PLAC8 Overexpression Promotes Lung Cancer Cell Growth via Wnt/β-Catenin Signaling

The Novel KLF4/PLAC8 Signaling Pathway Regulates Lung Cancer Growth.

PLCA8 Suppresses Breast Cancer Apoptosis by Activating the PI3k/AKT/NF‐κB Pathway

Multifaced roles of PLAC8 in cancer

Modification of PLAC8 by UFM1 Affects Tumorous Proliferation and Immune Response by Impacting PD-L1 Levels in Triple-Negative Breast Cancer.

Candidate oncogene placenta specific 8 affects cell growth and cell migration in non-small cell lung cancers

PLAC8 Contributes to the Malignant Behaviors of Cervical Cancer Cells by Activating the SOX4-mediated AKT Pathway

PLAC8 Facilitates Osteosarcoma Growth and Metastasis by Upregulating CXCL5 Expression Via Mir-363-3p

PLAC8 Promotes Adriamycin Resistance Via Blocking Autophagy in Breast Cancer

lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β‑catenin pathway in oral squamous cell carcinoma

Overexpression of TSPAN8 Promotes Tumor Cell Viability and Proliferation in Nonsmall Cell Lung Cancer.

CBX8 Promotes Epithelial-mesenchymal Transition, Migration, and Invasion of Lung Cancer through Wnt/β-catenin Signaling Pathway

PlGF knockdown attenuates hypoxia-induced stimulation of cell proliferation and glycolysis of lung adenocarcinoma through inhibiting Wnt/β-catenin pathway

Actin‐like Protein 8 Promotes Cell Proliferation, Colony‐formation, Proangiogenesis, Migration and Invasion in Lung Adenocarcinoma Cells

PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer

PLAC8 Overexpression Correlates with PD-L1 Upregulation and Acquired Resistance to Chemotherapies in Gallbladder Carcinoma.

Proteomic Analysis Reveals That Placenta-Specific Protein 9 Inhibits Proliferation and Stimulates Motility of Human Bronchial Epithelial Cells

LINC01207 Promotes the Progression of Non-Small Cell Lung Cancer Via Regulating ARHGAP11A by Sponging Mir-525-5p

Knockout of the Placenta Specific 8 Gene Affects the Proliferation and Migration of Human Embryonic Kidney 293T Cell

The oncogenic role of LGR6 overexpression induced by aberrant Wnt/β-catenin signaling in lung cancer

SLC6A8 is involved in the progression of non-small cell lung cancer through the Notch signaling pathway